0001127602-18-027101.txt : 20180907
0001127602-18-027101.hdr.sgml : 20180907
20180907161554
ACCESSION NUMBER: 0001127602-18-027101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180906
FILED AS OF DATE: 20180907
DATE AS OF CHANGE: 20180907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAUSEY CHRISTOPHER
CENTRAL INDEX KEY: 0001237334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 181060326
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-09-06
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001237334
CAUSEY CHRISTOPHER
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
Common Stock
2018-09-06
4
M
0
750
54.77
A
3925
D
Common Stock
2018-09-06
4
D
0
750
118.48
D
3175
D
Common Stock
2018-09-06
4
S
0
810
118.00
D
2365
D
Share Tracking Award
54.77
2018-09-06
4
M
0
750
0
D
2012-06-29
2021-06-29
Common Stock
750
1500
D
This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
This transaction was executed in multiple trades at prices ranging from $118.00 to $118.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2018-09-07